Catalyst Wire Dossier Catalyst Wire Dossier

rhTSH

recombinant human thyroid-stimulating hormone
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for rhTSH, covering 2023-10-23 to 2024-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal [Phase 3]

See pricing